TR200100450T2 - Salvia türlerinden elde edilen ve virüslere karşı etkili olan bileşikler - Google Patents
Salvia türlerinden elde edilen ve virüslere karşı etkili olan bileşiklerInfo
- Publication number
- TR200100450T2 TR200100450T2 TR2001/00450T TR200100450T TR200100450T2 TR 200100450 T2 TR200100450 T2 TR 200100450T2 TR 2001/00450 T TR2001/00450 T TR 2001/00450T TR 200100450 T TR200100450 T TR 200100450T TR 200100450 T2 TR200100450 T2 TR 200100450T2
- Authority
- TR
- Turkey
- Prior art keywords
- compounds
- effective against
- compounds derived
- against viruses
- tetramers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formül (1), Salvia bitki cinsinin ekstratlarinda bulunan Beta-(3,4-dihidroksifenil) laktik asit ve/veya kafeik asitten olusan en azindan bir kisma sahip moleküller içeren bilesimler saglanmistir; bu kisimlar, formül (I)'e sahiptirler; aktif maddeler, en azindan 190 daltonluk bir moleküler agirliga sahiptirler. Tercih edilen maddelerin bir sinifi, bahsedilen kisimlari içeren dimerler, trimerler, tetramerler ve daha büyük polimerler olusturmak için birlesmis maddelerdir; en çok tercih edilenler, salvianolik asidin dimerleri, trimerleri, tetramerleri ve daha büyük polimerleridir. Bilesikler ve bilesimler, virüs enfeksiyonlarinin tedavi edilmesi için sistemik veya lokal olarak farmasötik olarak kabul edilebilir tasiyicilarda ve eksipiyanlarda uygulanirlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/104,363 US6037369A (en) | 1998-06-25 | 1998-06-25 | Compounds obtained from salvia species having antiviral Activity |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200100450T2 true TR200100450T2 (tr) | 2001-07-23 |
Family
ID=22300096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/00450T TR200100450T2 (tr) | 1998-06-25 | 1999-06-25 | Salvia türlerinden elde edilen ve virüslere karşı etkili olan bileşikler |
Country Status (18)
Country | Link |
---|---|
US (1) | US6037369A (tr) |
EP (1) | EP1089747A1 (tr) |
JP (1) | JP2002518455A (tr) |
KR (1) | KR20010071580A (tr) |
CN (1) | CN1312722A (tr) |
AU (1) | AU740698B2 (tr) |
BR (1) | BR9912218A (tr) |
CA (1) | CA2335956A1 (tr) |
CZ (1) | CZ20004858A3 (tr) |
HU (1) | HUP0103398A2 (tr) |
ID (1) | ID28792A (tr) |
IL (1) | IL140483A0 (tr) |
IS (1) | IS5792A (tr) |
MX (1) | MXPA01000195A (tr) |
NO (1) | NO20006631L (tr) |
PL (1) | PL345086A1 (tr) |
TR (1) | TR200100450T2 (tr) |
WO (1) | WO1999066942A1 (tr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998024460A1 (en) * | 1996-12-05 | 1998-06-11 | Georgetown University | Extracts of salvia species having antiviral activity |
US6043276A (en) * | 1998-06-25 | 2000-03-28 | Georgetown University School Of Medicine | Compounds obtained from salvia species having antiviral activity |
EP1278531B1 (de) * | 2000-05-05 | 2005-09-21 | Parsenn-Produkte AG | Verwendung einer zubereitung zur topischen behandlung von durch virusinfektionen verursachten manifestationen |
SG98409A1 (en) * | 2000-06-21 | 2003-09-19 | Chi Chiang Yang | Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus |
JP2002020283A (ja) * | 2000-06-22 | 2002-01-23 | Yang Chi-Chiang | Hivおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ |
KR20020005222A (ko) * | 2000-06-28 | 2002-01-17 | 치-치앙 양 | Hiv 또는 레트로바이러스에 관련된 질환의 치료 또는예방용 약학적 조성물 및 조합물 |
AU2001293048A1 (en) * | 2000-09-26 | 2002-04-08 | The Johns Hopkins University | Antiviral compositions and methods of use |
US20070027209A1 (en) * | 2005-08-01 | 2007-02-01 | Lee Hyun C | Prevention and treatment of atherosclerosis with lithospermate B |
WO2008117901A1 (en) * | 2007-03-28 | 2008-10-02 | Industry-Academic Cooperation Foundation, Yonsei University | A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae |
KR20120006029A (ko) * | 2009-03-30 | 2012-01-17 | 티안진 타슬리 파마슈티컬 컴퍼니 리미티드 | 신규한 화합물 살비아놀릭산 l, 이의 제조방법 및 용도 |
CN101919836A (zh) * | 2009-06-17 | 2010-12-22 | 山东绿叶天然药物研究开发有限公司 | 迷迭香酸的新用途 |
CN103054976B (zh) * | 2011-10-21 | 2014-09-24 | 上海中医药大学 | 一种治疗血小板减少症的中药组合物及其制备方法和应用 |
CN103845403B (zh) * | 2014-02-27 | 2016-10-05 | 河南大学 | 丹参配方颗粒在制备预防和治疗艾滋病脑病药物方面的应用 |
CN104974119B (zh) * | 2014-04-01 | 2018-10-19 | 中国科学院上海药物研究所 | 一种高纯度丹酚酸b镁及其制备方法 |
CN108042524A (zh) * | 2017-12-21 | 2018-05-18 | 南方医科大学 | 丹酚酸b及其结构类似物在制备抗hpv病毒感染药物中的应用 |
CN109771410B (zh) * | 2019-03-06 | 2020-11-24 | 湖北大学 | 紫草酸在制备抗乙肝病毒药物中的用途 |
CN109771407B (zh) * | 2019-03-29 | 2021-11-26 | 成都医学院 | 迷迭香酸在制备抑制水痘-带状疱疹病毒的药物中的用途 |
CN110922286B (zh) * | 2019-11-23 | 2022-08-16 | 上海化工研究院有限公司 | 一种非对称芳基取代富烯化合物及其制备方法与应用 |
EP4144353A1 (en) * | 2020-04-30 | 2023-03-08 | FUJIFILM Toyama Chemical Co., Ltd. | Coronavirus infection therapeutic agent formed through combination of pyrazine derivative and another coronavirus infection therapeutic drug |
CN114712342B (zh) * | 2022-05-10 | 2023-04-21 | 湖北大学 | 紫草酸在制备抗流感病毒药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178865A (en) * | 1990-06-19 | 1993-01-12 | Cedars-Sinai Medical Center | Chinese herbal extracts in the treatment of hiv related disease in vitro |
US5346695A (en) * | 1991-03-27 | 1994-09-13 | Tampa Bay Research Institute | Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids |
WO1998024460A1 (en) * | 1996-12-05 | 1998-06-11 | Georgetown University | Extracts of salvia species having antiviral activity |
-
1998
- 1998-06-25 US US09/104,363 patent/US6037369A/en not_active Expired - Fee Related
-
1999
- 1999-06-25 EP EP99930658A patent/EP1089747A1/en not_active Withdrawn
- 1999-06-25 KR KR1020007014664A patent/KR20010071580A/ko not_active Application Discontinuation
- 1999-06-25 MX MXPA01000195A patent/MXPA01000195A/es not_active Application Discontinuation
- 1999-06-25 JP JP2000555628A patent/JP2002518455A/ja active Pending
- 1999-06-25 BR BR9912218-9A patent/BR9912218A/pt not_active Application Discontinuation
- 1999-06-25 CZ CZ20004858A patent/CZ20004858A3/cs unknown
- 1999-06-25 CN CN99809677A patent/CN1312722A/zh active Pending
- 1999-06-25 ID IDW20002741A patent/ID28792A/id unknown
- 1999-06-25 CA CA002335956A patent/CA2335956A1/en not_active Abandoned
- 1999-06-25 WO PCT/US1999/014297 patent/WO1999066942A1/en not_active Application Discontinuation
- 1999-06-25 TR TR2001/00450T patent/TR200100450T2/tr unknown
- 1999-06-25 PL PL99345086A patent/PL345086A1/xx unknown
- 1999-06-25 HU HU0103398A patent/HUP0103398A2/hu unknown
- 1999-06-25 AU AU47149/99A patent/AU740698B2/en not_active Ceased
- 1999-06-25 IL IL14048399A patent/IL140483A0/xx unknown
-
2000
- 2000-12-22 NO NO20006631A patent/NO20006631L/no not_active Application Discontinuation
- 2000-12-22 IS IS5792A patent/IS5792A/is unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010071580A (ko) | 2001-07-28 |
HUP0103398A2 (hu) | 2002-01-28 |
PL345086A1 (en) | 2001-12-03 |
BR9912218A (pt) | 2002-07-23 |
JP2002518455A (ja) | 2002-06-25 |
US6037369A (en) | 2000-03-14 |
WO1999066942A9 (en) | 2000-06-22 |
NO20006631D0 (no) | 2000-12-22 |
MXPA01000195A (es) | 2002-04-24 |
CN1312722A (zh) | 2001-09-12 |
ID28792A (id) | 2001-07-05 |
EP1089747A1 (en) | 2001-04-11 |
NO20006631L (no) | 2001-02-26 |
CZ20004858A3 (cs) | 2001-09-12 |
AU740698B2 (en) | 2001-11-15 |
WO1999066942A1 (en) | 1999-12-29 |
CA2335956A1 (en) | 1999-12-29 |
AU4714999A (en) | 2000-01-10 |
IS5792A (is) | 2000-12-22 |
IL140483A0 (en) | 2002-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200100450T2 (tr) | Salvia türlerinden elde edilen ve virüslere karşı etkili olan bileşikler | |
BR0013771A (pt) | Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica | |
BRPI0414045A (pt) | administração de ligantes de tlr7 e pró-medicamentos dos mesmos para tratamento de infecção por vìrus de hepatite c | |
BR9909730A (pt) | Dihidropirimidinas | |
EA199901031A1 (ru) | Производные бензимидазола | |
MY130477A (en) | Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome | |
ID27787A (id) | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan | |
DZ3165A1 (fr) | Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie. | |
BR0113666A (pt) | Inibidores da protease peptidomimética | |
BR9908275A (pt) | Inibidores de enzimas fosfolipase | |
DE69934010D1 (de) | Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten | |
ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
BR9813319A (pt) | Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto | |
DK0862634T4 (da) | Farmaceutisk præparat mod papillomavirustumorer og -infektioner | |
BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
ATE157370T1 (de) | Oligonukleotide mit wirkung gegen das respiratorische synzytial virus | |
DK1053012T3 (da) | Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner | |
RU95105983A (ru) | Ингибиторы тромбина, способы их получения и фармацевтическая композиция на их основе | |
NO20013167D0 (no) | Anvendelse av bisfosfonater for forebygging og behandling av infeksjonsprosesser | |
ATE309803T1 (de) | Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung | |
FR2791262B1 (fr) | Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs | |
TR200101832T2 (tr) | Organofosfor terkipleri ve bunların kullanılmaları. | |
DE69727583D1 (de) | Vermeidung von gastrointestinaler schädigung | |
BR0116554A (pt) | Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão | |
ATE247672T1 (de) | Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen |